Position in PTCT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,601,055
-$184,005 QoQ
Shares Held
23,500
0.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rathbones Group PLC holds $8,220,550 across 18 Biotechnology names. PTCT ranks #1 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
This page
|
23,500 | $1,601,055 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
23,666 | $1,376,177 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
153,420 | $1,176,731 | |
| 4 | ORMP |
Oramed Pharmaceuticals Inc.
|
233,018 | $792,261 | |
| 5 | MRNA |
Moderna, Inc.
|
13,778 | $699,922 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
30,200 | $570,780 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
955 | $426,445 | |
| 8 | VIR |
Vir Biotechnology, Inc.
|
28,611 | $256,354 |
All Filings in PTCT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,601,055 | 23,500 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,785,060 | 23,500 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,442,195 | 23,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,147,740 | 23,500 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,197,560 | 23,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,060,790 | 23,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $871,850 | 23,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $725,816 | 23,735 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $690,451 | 23,735 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $654,136 | 23,735 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $531,901 | 23,735 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||